The DOI matches its Crossref record; 43 of the 46 references it cites were found in a registry or an index.
Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.
Open accessAbstract
We have expressed six previously cloned isoforms of human microtubule-associated tau protein in Escherichia coli and purified them to homogeneity in a biologically active form. They range from 352 to 441 amino acids in length and differ from each other by the presence of three or four tandem repeats in the carboxy-terminal half and by the presence or absence of 29 or 58 amino acid inserts in the amino-terminus. When mixed together they gave a set of six bands on SDS-PAGE gels with apparent molecular weights of 48-67 kd and with a characteristic pattern of spacings. Four of these bands aligned with the major tau bands found in adult human cerebral cortex following perchloric acid extraction and alkaline phosphatase treatment. They consisted of isoforms with three repeats and no insertions, four repeats and no amino-terminal insertions and three- and four-repeat containing isoforms with the 29 amino acid insertion. In fetal human brain extracts treated with alkaline phosphatase one of the two major tau bands aligned with the three-repeat containing isoform with no insertions, whereas the molecular nature of the second major tau band remains to be established. The recombinant tau isoforms were biologically active at micromolar concentrations, as assessed by their ability to promote microtubule assembly. The rates of assembly were 2.5-3.0 times faster for isoforms containing four repeats when compared with three-repeat containing isoforms, with no significant contribution by the amino-terminal insertions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since tau binds to microtubules through C-terminal repeats within the microtubule-binding domain, 4R tau isoforms show a higher propensity to promote microtubule assembly compared to 3R tau isoforms [122, 123].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
[6] Use of T7 RNA polymerase to direct expression of cloned genes
Studier, F. W., Rosenberg, A. H., Dunn, J. J., & Dubendorff, J. W. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)85008-c · Cited by 6,562
Matsudaira, P. T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,951
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citationMicrotubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
The distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,491
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Self-citation
Research works printed but not linked: 7
- Goedert,M., Wischik,C.M., Crowther,R.A., Walker,J.E. and Klug,A. (1988) Proc. Natl. Acad. Sci. USA, 85, 4051-4055.
- Hirel,P.H., Schmitter,J.M., Dessen,P., Fayat,G. and Blanquet,S. (1989) Proc. Natl. Acad. Sci. USA, 86, 8247-8251.
- Kosik,K.S., Joachim,C.L. and Selkoe,D.J. (1986) Proc. Natl. Acad. Sci. USA, 83, 4044-4048.
- Weingarten,M.D., Lockwood,A.H., Hwo,S.Y. and Kirschner,M.W. (1975) Proc. Natl. Acad. Sci. USA, 72, 1858-1862.
- Wischik,C.M., Novak,M., Th0gersen,H.C., Edwards,P.C., Runswick,M.J., Jakes,R., Walker,J.E., Milstein,C., Roth,M. and Klug,A. (1988a) Proc. Natl. Acad. Sci. USA, 85, 4506-4510.
- Wischik,C.M., Novak,M., Edwards,P.C., Klug,A., Tichelaar,W. and Crowther,R.A. (1988b) Proc. Natl. Acad. Sci. USA, 85, 4884-4888.
- Wood,J.G., Mirra,S.S., Pollock,N.J. and Binder,L.I. (1986) Proc. Natl. Acad. Sci. USA, 83, 4040-4043. Received on August 28, 1990 4230 14602075, 1990, 13, Downloaded from https://www.embopress.org/doi/10.1002/j.1460-2075.1990.tb07870.x by Readcube (Labtiva Inc.), Wiley Online Library on [14/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License · DOI
Cited by
Sorted by citations
Items 201–300 of 929
Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
Hanes, J., Zilka, N., Bartkova, M., Caletkova, M., Dobrota, D., & Novak, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05869.x · Cited by 109
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau
Götz, J., Tolnay, M., Barmettler, R., Chen, F., Probst, A., & Nitsch, R. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01604.x · Cited by 107
“Tau is an axonal, microtubule-associated phosphoprotein in normal adult brain that has tubulin-polymerizing activities in vitro (Goedert & Jakes, 1990; Brandt & Lee, 1994).”
BackgroundHarrington, C. R., Storey, J. M. D., Clunas, S., Harrington, K. A., Horsley, D., Ishaq, A., Kemp, S. J., Larch, C. P., Marshall, C., Nicoll, S. L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616029 · Cited by 107
“These proteins were purified from bacterial cell lysates using P-11 phosphocellulose ion exchange chromatography (16).”
MethodJanke, C., Beck, M., Stahl, T., Holzer, M., Brauer, K., Bigl, V., & Arendt, T. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00079-0 · Cited by 104
Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
Rao, S. S., & Adlard, P. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00276 · Cited by 108
“Under physiological conditions, 3R and 4R tau isoforms are expressed equally in most regions of the brain (Goedert and Jakes, 1990).”
BackgroundInsights into Disease-Associated Tau Impact on Mitochondria
Szabo, L., Eckert, A., & Grimm, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176344 · Cited by 107
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
Mroczko, B., Groblewska, M., & Litman‐Zawadzka, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194661 · Cited by 111
“Attenuated MT binding by fetal isoform 3R in the postnatal period, when compared to the 4R isoform, is critical for brain development and may be related to higher synaptic plasticity [44,48].”
BackgroundInfluentialThree Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments
Adams, S. J., Deture, M. A., McBride, M., Dickson, D. W., & Petrucelli, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010810 · Cited by 110
“[4,14], but may also affect tau aggregation.”
Prion-like Spreading in Tauopathies
Ayers, J. I., Giasson, B. I., & Borchelt, D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.04.003 · Cited by 106
“Nevertheless, 4R tau has a greater MT polymerization and binding capacity than 3R-tau (28, 46).”
BackgroundExosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar, E., Seresht, B. M., Momeni, F., Fadaei, E., Mehr, M. H., Ebrahimi, Z., Rahmati, M., Kharazinejad, E., & Mirzaei, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27214 · Cited by 93
“It has been showed that deregulation of 3R/4R expression is associated with decrease the function of tau, which has critical roles in material transport and keeping stabilization of microtubule structure (Goedert & Jakes, 1990).”
BackgroundPathological Changes of Tau Related to Alzheimer’s Disease
Chu, D., & Liu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 106
The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family
Spina, S., Farlow, M. R., Unverzagt, F. W., Kareken, D. A., Murrell, J. R., Fraser, G. M., Epperson, F., Crowther, R. A., Spillantini, M. G., Goedert, M., et al. (2007) · Brain · doi:10.1093/brain/awm280 · Cited by 98
“In normal adult human brain, 6 tau proteins are expressed, with similar levels of 3-repeat and 4-repeat isoforms (Goedert et al., 1989; Goedert and Jakes, 1990).”
BackgroundSelf-citationMicrotubule-dependent Oligomerization of Tau
Makrides, V., Shen, T. E., Bhatia, R., Smith, B. L., Thimm, J. C., Lal, R., & Feinstein, S. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305207200 · Cited by 102
Bussière, T., Hof, P. R., Vanbesien-Mailliot, C., Brown, C., Caillet‐Boudin, M., Perl, D. P., Buée, L., & Delacourte, A. (1999) · Acta Neuropathologica · doi:10.1007/s004010050978 · Cited by 102
Levy, S. F., LeBoeuf, A. C., Massie, M. R., Jordan, M. A., Wilson, L., & Feinstein, S. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413490200 · Cited by 102
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A
Wu, Q., Liang, H., Shi, J., Jin, N., Grundke, I., Iqbal, K., Gong, C., & Liu, F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr195 · Cited by 100
“Approximately equal amount of 3R-tau and 4R-tau are expressed in normal adult human brain (8,9).”
BackgroundChapin, S. J., & Bulinski, J. C. (1992) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970230403 · Cited by 100
Tau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, L., Eckert, A., Ittner, L. M., Piguet, O., & Götz, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13600 · Cited by 104
“The presence of the repeat motifs correlates with the capacity of tau to bind, and thus stabilize, microtubules, with 4R increasing the interaction with microtubules (Goedert et al. 1989; Goedert and Jakes 1990).”
BackgroundTau mis-splicing in the pathogenesis of neurodegenerative disorders
Park, S. A., Ahn, S. I., & Gallo, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.8.084 · Cited by 100
“Exons 2 and 3 are translated into the N1 and N2 aspects of the N-terminal projection domain, respectively (15), which play important roles in signal”
BackgroundInfluentialOverexpression of full- or partial-length MAP4 stabilizes microtubules and alters cell growth
Nguyen, H.-L., Chari, S., Gruber, D., Lue, C.-M., Chapin, S. J., & Bulinski, J. C. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.2.281 · Cited by 101
Targeting tau: clinical trials and novel therapeutic approaches
VandeVrede, L., Boxer, A. L., & Polydoro, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134919 · Cited by 90
Whittington, R. A., Bretteville, A., Dickler, M., & Planel, E. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.004 · Cited by 101
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
Wolfe, M. S. (2012) · Scientifica · doi:10.6064/2012/796024 · Cited by 105
Mulot, S., Hughes, K., Woodgett, J. R., Anderton, B. H., & Hanger, D. P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00702-0 · Cited by 96
Characteristics and consequences of muscarinic receptor activation by tau protein
Gómez‐Ramos, A., Dı́az-Hernández, M., Rubio, A., Díaz‐Hernandéz, J. I., Miras‐Portugal, M. T., & Ávila, J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.04.006 · Cited by 95
“The recombinant tau isoform containing 2 N-terminal inserts and 4 microtubule binding repeats (tau42: Goedert and Jakes, 1990), was isolated as described previously (Perez et al., 1996).”
MethodA functional role for intrinsic disorder in the tau-tubulin complex
Melo, A. M., Coraor, J., Cobb, G., Elbaum‐Garfinkle, S., Nath, A., & Rhoades, E. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610137113 · Cited by 97
“1) have lower microtubule binding affinities (9, 11) and assembly activity (41) and stabilize microtubules more weakly than tau2N4R (42), suggesting functional and potentially structural consequences of R2.”
BackgroundFemtomolar Detection of Tau Proteins in Undiluted Plasma Using Surface Plasmon Resonance
Kim, S., Wark, A. W., & Lee, H. J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01825 · Cited by 93
Reid, M. J., Beltran-Lobo, P., Johnson, L., Perez‐Nievas, B. G., & Noble, W. J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.572850 · Cited by 98
“Tau isoforms are developmentally regulated; the 58 shortest 0N3R isoform is expressed in the fetal brain whereas in the adult human brain 3R and 4R 59 isoforms are equally represented (Goedert and Jakes, 1990).”
BackgroundBrunden, K. R., Ballatore, C., Crowe, A., Smith, Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.031 · Cited by 93
“R versions (Goedert and Jakes, 1990; Panda et al., 2003), and in normal cells the amount of 4-”
Bell, M. J., & Zempel, H. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0152 · Cited by 92
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease
Rosa, E., Mahendram, S., Ke, Y. D., Ittner, L. M., Ginsberg, S. D., & Fahnestock, M. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.020 · Cited by 92
“In a healthy adult, the ratio of 3R:4R tau isoforms is approximately 1:1 in most regions of the brain (Goedert and Jakes, 1990; Hong, et al., 1998; Kosik, et al., 1989).”
The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy
Zhang, C., Xing, A., Tan, M., Tan, L., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9415-8 · Cited by 98
“Compared to 3R-tau, 4R-tau was almost three times faster for the rates of promoting to microtubule assemble, regardless of the amino-terminal inserts [17].”
BackgroundBrandt, R., Trushina, N. I., & Bakota, L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590059 · Cited by 97
“In the human central nervous system (CNS), six different isoforms are present, which differ by the presence or absence of three alternatively spliced exons, exon 2, 3, and 10 (2).”
BackgroundElevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease
Norlund, M. A., Lee, J. M., Zainelli, G. M., & Muma, N. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02179-4 · Cited by 93
The domestic cat as a natural animal model of Alzheimer’s disease
CHAMBERS, J. K., Tokuda, T., Uchida, K., Ishii, R., Tatebe, H., Takahashi, E., Tomiyama, T., Une, Y., & Nakayama, H. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0258-3 · Cited by 90
Ojo, J. O., Mouzon, B., & Crawford, F. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.06.003 · Cited by 89
Doll, T., Meichsner, M., Riederer, B. M., Honegger, P., & Matus, A. I. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.2.633 · Cited by 90
A validated antibody panel for the characterization of tau post-translational modifications
Ercan-Herbst, E., Eid, S., Weber, C., Kowalski, A., Bichmann, M., Behrendt, A., Matthes, F., Krauß, S., Reinhardt, P., Fulle, S., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0229-1 · Cited by 92
“Protein purification was performed as previously described with modifications described below [9].”
AlphaFold and the amyloid landscape
Pinheiro, F., Santos, J., & Ventura, S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167059 · Cited by 88
Wren, M. C., Zhao, J., Liu, C., Murray, M. E., Atagi, Y., Davis, M. D., Fu, Y., Okano, H. J., Ogaki, K., Strongosky, A. J., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0042-7 · Cited by 86
“Whereas 4R-tau protein is shown to have a stronger interaction with microtubules than 3R-tau, 4R-tau is also more effective at assembling microtubules [23]; the N279K mutation does not appear to affect the binding of tau to microtubules or decrease the ability of tau to promote microtubule assembly when compared to wi…”
BackgroundRai, H., Gupta, S., Kumar, S., Yang, J., Singh, S. K., Ran, C., & Modi, G. P. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01619 · Cited by 87
Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells
Nie, C. L., Wang, X. S., Liu, Y. M., Perrett, S., & He, R. Q. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-9 · Cited by 86
“(1990) [58].”
Greenwood, J. A., Scott, C. W., Spreen, R. C., Caputo, C. B., & Johnson, G. V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41790-x · Cited by 86
Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau
Goedert, M., Spillantini, M. G., & Jakes, R. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90541-z · Cited by 86
Self-citationCytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models
Mukadam, A. S., Miller, L. V. C., Smith, A. E., Vaysburd, M., Sakya, S. A., Sanford, S., Keeling, S., Tuck, B. J., Katsinelos, T., Green, C., et al. (2023) · Science · doi:10.1126/science.abn1366 · Cited by 84
Self-citationPhosphorylation of microtubule‐associated protein tau by AMPK‐related kinases
Yoshida, H., & Goedert, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07523.x · Cited by 85
Self-citationCulbert, A. A., Brown, M. J. B., Frame, S., Hagen, T., Cross, D. A. E., Bax, B. D., & Reith, A. D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02990-8 · Cited by 85
Tau can switch microtubule network organizations: from random networks to dynamic and stable bundles
Prezel, E., Elie, A., Delaroche, J., Stoppin-Mellet, V., Bosc, C., Serre, L., Fourest-Lieuvin, A., Andrieux, A., Vantard, M., & Arnal, I. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-06-0429 · Cited by 83
“This result correlates with the weaker microtubule number (three or four) of repeats (Himmler et al., 1989; Goedert and Jakes, 1990).”
ResultNunez, J., & Fischer, I. (1997) · Journal of Molecular Neuroscience · doi:10.1007/bf02736834 · Cited by 83
Ikeda, H., Taira, N., Hara, F., Fujita, T., Yamamoto, H., Soh, J., Toyooka, S., Nogami, T., Shien, T., Doihara, H., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2598 · Cited by 82
van Herpen, E., Rosso, S. M., Serverijnen, L., Yoshida, H., Breedveld, G. J., van de Graaf, R., Kamphorst, W., Ravid, R., Willemsen, R., Dooijes, D., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10721 · Cited by 83
“Wild-type and mutant tau proteins were expressed in Escherichia coli BL21 (DE3), as described.(11) 3R tau with the K257T mutation and 4R tau with the K280 mutation served as controls.”
BackgroundMethodSelf-citationSingh, T. J., Haque, N., Grundke, I., & Iqbal, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01445-7 · Cited by 83
Huang, D. Y., Goedert, M., Jakes, R., Weisgraber, K. H., Garner, C. C., Saunders, A. M., Pericak‐Vance, M. A., Schmechel, D. E., Roses, A. D., & Strittmatter, W. J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90204-6 · Cited by 83
Self-citationOkadaic acid induces hyperphosphorylated forms of tau protein in human brain slices
Harris, K. A., Oyler, G., Doolittle, G. M., Vincent, I., Lehman, R. A. W., Kincaid, R. L., & Billingsley, M. L. (1993) · Annals of Neurology · doi:10.1002/ana.410330113 · Cited by 97
Feuillette, S., Miguel, L., Frébourg, T., Campion, D., & Lecourtois, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06663.x · Cited by 81
Merrick, S. E., Demoise, D. C., & Lee, V. M. ‐. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5589 · Cited by 81
Distribution of big tau in the central nervous system of the adult and developing rat
Boyne, L. J., Tessler, A. R., Murray, M., & Fischer, I. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903580209 · Cited by 80
Current directions in tau research: Highlights from Tau 2020
Sexton, C. E., Snyder, H. M., Beher, D., Boxer, A. L., Brannelly, P., Brion, J., Buée, L., Cacace, A. M., Chételat, G., Citron, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12452 · Cited by 89
Planel, E., Krishnamurthy, P., Miyasaka, T., Liu, L., Herman, M., Kumar, A., Bretteville, A., Figueroa, H. Y., Haung Yu, W., Whittington, R. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-08.2008 · Cited by 79
“3R tau has been demonstrated to bind to MTs more weakly than 4R tau (Butner and Kirschner, 1991), and to be less efficient at promoting microtubule assembly (Goedert and Jakes, 1990; Gustke et al., 1994; Panda et al., 2003).”
Animal models reveal role for tau phosphorylation in human disease
Götz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D. C., & Ittner, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.008 · Cited by 82
“In contrast to humans, mice express only four-repeat tau isoforms (4R0N, 4R1N, or 4R2N) [9].”
Dawson, H. N., Cantillana, V., Chen, L., & Vitek, M. P. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5492-06.2007 · Cited by 80
“The 4R tau isoforms contain additional amino acids encoded by exon 10 that are absent in the 3R isoforms (Goedert and Jakes, 1990; Shahani and Brandt, 2002).”
BackgroundDifferences in microtubule binding and self-association abilities of bovine brain tau isoforms.
de Ancos, J. G., Correas, I., & Ávila, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53053-2 · Cited by 79
Tau Protein and Adult Hippocampal Neurogenesis
Fuster-Matanzo, A., Llorens-Martı́n, M., Jurado‐Arjona, J., Ávila, J., & Hernández, F. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00104 · Cited by 85
“Tau-4R isoforms promote microtubule assembly at a faster rate than the tau-3R isoforms (Goedert and Jakes, 1990), suggesting that tau-3R protein may aid newborn neurons to differentiate www.frontiersin.org July 2012 | Volume 6 | Article 104 | 3 by decreasing microtubule stability.”
BackgroundGong, C., Liu, F., Grundke, I., & Iqbal, K. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31825 · Cited by 81
“Only the shortest isoform of tau is expressed in fetal brain, whereas all six isoforms are seen in adult brain [39, 40].”
BackgroundTau isoform expression and phosphorylation state during differentiation of cultured neuronal cells
Smith, C. J., Anderton, B. H., Davis, D. R., & Gallo, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01221-y · Cited by 78
The Ubiquitin System in Alzheimer’s Disease
Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 79
Chiavaioli, F. E., Santano, D., Villar, I. D., Socorro-Leranoz, A. B., Zhang, X., Li, K., Santamaría, E., Fernández‐Irigoyen, J., Baldini, F., van den Hove, D., et al. (2022) · Advanced Photonics Research · doi:10.1002/adpr.202200044 · Cited by 79
Mochizuki, A., Ueda, Y., Komatsuzaki, Y., Tsuchiya, K., Arai, T., & Shoji, S. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0682-5 · Cited by 77
Boutajangout, A., Boom, A., Leroy, K., & Brion, J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.011 · Cited by 77
The Neurofibrillary Pathology of Alzheimer's Disease
Goedert, M. (1997) · The Neuroscientist · doi:10.1177/107385849700300212 · Cited by 77
Self-citationMicrotubule-associated protein tau as a therapeutic target in Alzheimer's disease
Iqbal, K., Gong, C., & Liu, F. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.870156 · Cited by 76
“In normal adult brain, there are six isoforms of tau, which are products of alternative splicing of the pre-mRNA coded by a single gene residing on chromosome 17 [16].”
BackgroundAggregate-selective removal of pathological tau by clustering-activated degraders
Benn, J., Cheng, S., Keeling, S., Smith, A. E., Vaysburd, M. J., Böken, D., Miller, L. V. C., Katsinelos, T., Franco, C., Dupré, E., et al. (2024) · Science · doi:10.1126/science.adp5186 · Cited by 81
Buchholz, S., Bell, M. J., Klimek, J., & Zempel, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.643115 · Cited by 75
Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
Boyarko, B., & HOOK, V. Y. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.702788 · Cited by 81
“0 times more rapidly compared to 3R tau isoforms, with no contributions by differences in amino-terminal insertions (Goedert and Jakes, 1990).”
BackgroundInfluentialWang, X., Dong, C., Zhang, J., Wan, Y.-Z., Li, F., Huang, Y.-X., Han, L., Shan, B., Gao, C., Han, J., et al. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9664-6 · Cited by 75
“known capable of regulating the microtubule polymer state and promoting microtubule assembly and stability [1–4].”
BackgroundProteolysis of Non-phosphorylated and Phosphorylated Tau by Thrombin
Arai, T., Guo, J., & McGeer, P. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409234200 · Cited by 75
Chapter 21 Neurofibrillary pathology of Alzheimer's disease and other tauopathies
Goedert, M. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64022-4 · Cited by 77
Self-citationThe Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 76
“Since the 4R tau isoforms contain an extra MT-binding repeat R2, they show higher affinity with MTs than the 3R isoforms (Goedert and Jakes 1990).”
BackgroundInfluentialDuan, A. R., Jonasson, E. M., Alberico, E. O., Li, C., Scripture, J. P., Miller, R. A., Alber, M., & Goodson, H. V. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.018 · Cited by 85
Ordered Assembly of Tau Protein and Neurodegeneration
Goedert, M., & Spillantini, M. G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_1 · Cited by 74
Self-citationPhosphorylation by Neuronal cdc2-like Protein Kinase Promotes Dimerization of Tau Protein in Vitro
Paudel, H. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28328 · Cited by 73
Giustiniani, J., Chambraud, B., Sardin, E., Dounane, O., Guillemeau, K., Nakatani, H., Paquet, D., Kamah, A., Landrieu, I., Lippens, G. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402645111 · Cited by 72
“Escherichia coli and purified as described (27).”
Structure of Tau filaments in Prion protein amyloidoses
Hallinan, G. I., Hoq, M. R., Ghosh, M., Vago, F. S., Fernández, A., Garringer, H. J., Vidal, R., Jiang, W., & Ghetti, B. F. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02336-w · Cited by 77
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Tarutani, A., Adachi, T., Akatsu, H., Hashizume, Y., Hasegawa, K., Saito, Y., Robinson, A., Mann, D. M. A., Yoshida, M., Murayama, S., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02426-3 · Cited by 74
“The expression ratio of 3R tau to 4R tau is about 1:1 [109].”
BackgroundTau Phosphorylation and Cleavage in Ethanol-Induced Neurodegeneration in the Developing Mouse Brain
Saito, M., Chakraborty, G., Mao, R.-F., Paik, S.-M., Vadász, C., & Saito, M. (2010) · Neurochemical Research · doi:10.1007/s11064-009-0116-4 · Cited by 72
“This form is highly phosphorylated and recognized by PHF-1 antibody [12], although it is less phosphorylated compared to the paired helical filament tau observed in tauopathies and retains a low but significant level of activity for promoting tubulin assembly [21].”
Hasegawa, M. (2016) · Biomolecules · doi:10.3390/biom6020024 · Cited by 75
“coli, cultured mammalian cells, and brain tissues [26,27].”
BackgroundMechanism of neurofibrillary degeneration in Alzheimer's disease
Iqbal, K., Alonso, A. D. C., Gong, C., Khatoon, S., Singh, T. J., & Grundke, I. (1994) · Molecular Neurobiology · doi:10.1007/bf02816111 · Cited by 72
Tubulin structure and biochemistry
Ludueña, R. F., Banerjee, A. K., & KHAN, I. A. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90058-k · Cited by 70
Candelise, N., Scaricamazza, S., Salvatori, I., Ferri, A., Valle, C., Manganelli, V., Garofalo, T., Sorice, M., & Misasi, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116016 · Cited by 72
Kulbe, J. R., & Hall, E. D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.003 · Cited by 70
“Healthy adult brains express equal ratios of 3R and 4R tau (Goedert and Jakes, 1990; Ojo et al., 2016), whereas rats and mice express 4R tau, an isoform which is preferentially phosphorylated and prone to aggregation, to a much higher degree than 3R tau (Hanes et al., 2009; McMillan et al., 2008;…”
BackgroundInfluentialJicha, G. A., Donnell, A. O., Weaver, C., Angeletti, R., & Davies, P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720214.x · Cited by 71
“…in this region of the tau molecule composing the fourth microtubule binding repeat have been shown to influence the association between tau and microtubule arrays (Goedert and Jakes, 1990; Drechsel et al., 1992; Raffaelli et al., 1992; Biernat et al., 1993; for review, see Lee, 1993).”
BackgroundInfluentialEnhancing Top-Down Proteomics of Brain Tissue with FAIMS
Fulcher, J. M., Makaju, A., Moore, R. J., Zhou, M., Bennett, D. A., De Jager, P. L., Qian, W.-J., Paša-Tolić, L., & Petyuk, V. A. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00049 · Cited by 68
Lye, J. J., Latorre, E., Lee, B. P., Bandinelli, S., Holley, J. E., Gutowski, N. J., Ferrucci, L., & Harries, L. W. (2019) · GeroScience · doi:10.1007/s11357-019-00100-3 · Cited by 69
Tau gene (MAPT) sequence variation among primates
Holzer, M., Craxton, M., Jakes, R., Arendt, T., & Goedert, M. (2004) · Gene · doi:10.1016/j.gene.2004.07.013 · Cited by 67
“In normal adult human cerebral cortex, there are similar levels of threerepeat and four-repeat tau isoforms (Goedert and Jakes, 1990).”
BackgroundSelf-citationAn immunochemical study on tau glycation in paired helical filaments
Ko, L., Ko, E. C., Nacharaju, P., Liu, W.-K., Chang, E. C., Kenessey, Á., & Yen, S.-H. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01415-8 · Cited by 68
Goedert, M., Crowther, R. A., Scheres, S. H. W., & Spillantini, M. G. (2023) · Cytoskeleton · doi:10.1002/cm.21812 · Cited by 64
“3R and 4R tau are present at similar levels in adult human brains (Goedert & Jakes, 1990).”
BackgroundSelf-citationUtton, M. A., Connell, J. W., Asuni, A. A., van Slegtenhorst, M., Hutton, M. L., de Silva, R., Lees, A. J., Miller, C. C. J., & Anderton, B. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06394.2002 · Cited by 66
Rank, K. B., Pauley, A. M., Bhattacharya, K., Wang, Z., EVANS, D. B., Fleck, T. J., Johnston, J. A., & Sharma, S. K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02376-1 · Cited by 66
Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
Hasegawa, M., Nonaka, T., & Masuda‐Suzukake, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.010 · Cited by 71
Capano, L. S., Sato, C., Ficulle, E., Yu, A., Horie, K., Kwon, J.-S., Burbach, K. F., Barthélemy, N. R., Fox, S. G., Karch, C. M., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.018 · Cited by 65
Metadata
- Authors
- Goedert, M., & Jakes, R.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- ORCID
- Goedert, M.
- Venue
- The EMBO Journal
- Published
- 1990-12-01
- Volume
- 9
- Issue
- 13
- Pages
- 4225-4230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC552204
- OpenAlex
- W1509571186
- Cited by
- 929
- References
- 46
- Citations by year
- 2026: 23 · 2025: 29 · 2024: 50 · 2023: 39 · 2022: 40 · 2021: 53 · 2020: 34 · 2019: 39 · 2018: 42 · 2017: 41 · 2016: 27 · 2015: 37 · 2014: 18 · 2013: 21 · 2012: 25
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tau isoforms, microtubule-associated proteins, microtubule assembly, tandem repeats, recombinant protein expression, cerebral cortex, fetal brain
- MeSH terms
- Aged, Alkaline Phosphatase, Alzheimer Disease, Amino Acid Sequence, Brain, Escherichia coli, Humans, Isomerism, Microtubule-Associated Proteins, Middle Aged, Molecular Sequence Data, Recombinant Proteins, Repetitive Sequences, Nucleic Acid, RNA Splicing, RNA, Messenger, Tubulin, Mutagenesis, Site-Directed, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review